4.7 Review

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

期刊

BIOLOGICAL PSYCHIATRY
卷 65, 期 9, 页码 732-741

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2008.11.029

关键词

Cytokines; depression; excitotoxicity; hypothalamic-pituitary-adrenal axis; inflammation; monoamines; stress

资金

  1. National Institutes of Health (NIH) [K05 MH069724, K23 MH064679, R01 MH070553, 1101 HL073921, 132 MH020018]
  2. NIH/National Center for Research Resources (NCRR) General Clinical Research Center [M01 RR00039]
  3. Centers for Disease Control and Prevention
  4. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER
  5. NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER
  6. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073921] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH069124, T32MH020018, R01MH070553, R01MH083746, K23MH064619] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Recognition that inflammation may represent a common mechanism of disease has been extended to include neuropsychiatric disorders including major depression. Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines, which have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Indeed, activation of inflammatory pathways within the brain is believed to contribute to a confluence of decreased neurotrophic support and altered glutamate release/reuptake, as well as oxidative stress, leading to excitotoxicity and loss of glial elements, consistent with neuropathologic findings that characterize depressive disorders. Further instantiating the link between inflammation and depression are data demonstrating that psychosocial stress, a well-known precipitant of mood disorders, is capable of stimulating inflammatory signaling molecules, including nuclear factor kappa B, in part, through activation of sympathetic nervous system outflow pathways. Interestingly, depressed patients with increased inflammatory biomarkers have been found to be more likely to exhibit treatment resistance, and in several studies, antidepressant therapy has been associated with decreased inflammatory responses. Finally, preliminary data from patients with inflammatory disorders, as well as medically healthy depressed patients, suggest that inhibiting proinflammatory cytokines or their signaling pathways may improve depressed mood and increase treatment response to conventional antidepressant medication. Translational implications of these findings include the unique opportunity to identify relevant patient populations, apply immune-targeted therapies, and monitor therapeutic efficacy at the level of the immune system in addition to behavior.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据